THER ADV HEMATOL 润色咨询

Therapeutic Advances in Hematology

出版年份:2010 年文章数:352 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=2ba615004, cover=https://img.medsci.cn/20231103/1698991804199_1614372.jpg, fullname=Therapeutic Advances in Hematology, abbr=THER ADV HEMATOL, pyear=2010, frequence=null, articleNumbers=352, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2040-6207, greenSci=https://www.greensci.net/search?kw=2040-6207, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-HEMATOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.493, medsciHotlight=2.127, medsciHotlight5year=0.8998, citescore=0.0, hIndex=0, impactFactor=3.4, orgnization=Sage Publications, orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Current Contents - Life Sciences Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus, bigclassCas=医学 3区, smallclassCas=医学 2 区, website=https://journals.sagepub.com/home/TAH?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, websiteHits=704, guideForAuthor=https://journals.sagepub.com/author-instructions/TAH?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, guideForAuthorHits=339, submitWebsite=https://mc.manuscriptcentral.com/tah?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, submitWebsiteHits=379, content=<p>该刊是一份经过同行评审的开放获取期刊,提供高质量原创研究、综述等,内容涉及血液学相关领域的开拓性工作和创新性研究。</p>, totalCites=1199, brief=THER ADV HEMATOL杂志暂不明确行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=血液学" >血液学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=THER ADV HEMATOL在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=2ba615004'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=1.974), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.525), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.282), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=6.917), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.493)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2040-6207[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Therapeutic Advances in Hematology[ta], article_number=55, article_number_cn=12, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
THER ADV HEMATOL/Therapeutic Advances in Hematology
ISSN
2040-6207
影响指数话题
预警等级
MedSci期刊指数
3.493 (MedSci实时期刊指数) | 0.8998 (5年期刊指数)
CiteScore值
0.0
h-index
0
h5-median
暂无数据
出版社/管理机构
杂志由 Sage Publications 出版或管理
出版国家/地区
United States 美国
出版周期
暂无数据
出版年份
2010
是否OA
被收录情况
Clarivate Analytics: Current Contents - Life Sciences Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus
JCR分区
暂无数据
中科院分区
大类:医学 3区
小类:医学 2 区